TerminatedPhase 2/3

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

Stopped: PI moved to Oregon

United States54 participantsStarted 2001-05

Plain-language summary

Patients who receive radiation therapy often have fatigue or a decrease in feeling well causing a "wasting" away. For patients with advanced disease of lung cancer, prostate cancer, or cancer that has spread to the bone, it is hoped that this drug may decrease this. If patients feel better during treatments they can complete the therapy without any breaks in treatment. For treatment to be most effective, it should be given in the amount needed, on a particular schedule.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Advanced lung, prostate, or bony metastasis for cancer * Performance status (PS) of 3 or less * Good lab test results with albumin of at least 2.5 * Radiation therapy of at least 4000Gy in 4 weeks Exclusion Criteria: * Poor PS * Planned radiation therapy for less than 4 weeks or 4000Gy * Limited disease

What they're measuring

Determine if the subjects who received the enbrel study drug had a better quality of life than the subjects who received placebo

Trial details

NCT IDNCT00127387

SponsorThe University of Texas Health Science Center at San Antonio

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2005-09

View on ClinicalTrials.gov More Lung Cancer trials